Skip to main content


Defending the 'middlemen' in the battle on drug prices

By The Hill  
   May 15, 2018

Pharmacy benefit managers (PBM) — the “middlemen” in drug price negotiations — are under attack, and, for the past 15 years, Mark Merritt has been the point man in charge of defending them.

Full story

Get the latest on healthcare leadership in your inbox.